Recent clinical trends in Toll‐like receptor targeting therapeutics
Muhammad Ayaz Anwar(University of the Punjab), Sangdun Choi(Ajou University), Jason Kim(University of California, Los Angeles), Masaud Shah(Ajou University)
Cited by 281
Related Papers
Mechanism of Cisplatin-Induced Cytotoxicity Is Correlated to Impaired Metabolism Due to Mitochondrial ROS Generation
|PLoS ONE|2015|285
Negative regulatory approaches to the attenuation of Toll-like receptor signaling
|Experimental & Molecular Medicine|2013|140
Osteopontin modulates angiotensin II–induced inflammation, oxidative stress, and fibrosis of the kidney
|Kidney International|2009|117
Doxorubicin-induced necrosis is mediated by poly-(ADP-ribose) polymerase 1 (PARP1) but is independent of p53
|Scientific Reports|2015|110
Multiple Roles of Toll-Like Receptor 4 in Colorectal Cancer
|Frontiers in Immunology|2014|105